Premium
Demonstration of an immune‐mediated mechanism of penicillin‐induced neutropenia and thrombocytopenia
Author(s) -
Murphy M. F.,
Riordan T.,
Minchinton R. M.,
Chapman J. F.,
Amess J. A. L.,
Shaw E. J.,
Waters A. H.
Publication year - 1983
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/j.1365-2141.1983.tb01233.x
Subject(s) - penicillin , neutropenia , medicine , platelet , immunology , immune thrombocytopenia , immune system , bone marrow , antibody , antibiotics , microbiology and biotechnology , chemotherapy , biology
S ummary . Severe neutropenia may be a more common complication of high‐dose penicillin therapy than previously recognized. This report describes five such patients, one of whom also had thrombocytopenia. The neutrophil and platelet counts rapidly increased on stopping penicillin, and the bone‐marrow, which was hypocellular in some cases, became normal. Further studies on one of these patients, using a fluorescent antiglobulin technique with paraformaldehyde‐fixed cells, demonstrated a complement‐fixing IgG penicillin antibody reacting with the patient's granulocytes and platelets in the presence of the drug. This suggested an immune mechanism similar to the well‐recognized penicillin‐induced immune haemolytic anaemia. The associated bone‐marrow hypoplasia may also be due to antibody‐mediated suppression of penicillin‐coated precursor cells.